Cash, Cash Equivalents, Restricted Cash and Short-Term Investments
3 Months Ended
Apr. 30, 2021
Investments, Debt and Equity Securities [Abstract]  
Cash, Cash Equivalents, Restricted Cash and Short-Term Investments Cash, Cash Equivalents, Restricted Cash and Short-Term Investments
Cash and Cash Equivalents
Cash and cash equivalents totaled $5.6 billion and $4.7 billion as of April 30, 2021 and January 29, 2021, respectively. Cash equivalents were $4.8 billion as of April 30, 2021 and consisted of money-market funds of $4.7 billion and time deposits of $89 million. Cash equivalents were $3.8 billion as of January 29, 2021 and consisted of money-market funds of $3.7 billion and time deposits of $102 million.
Restricted Cash
The following table provides a reconciliation of the Company’s cash and cash equivalents, and current and non-current portion of restricted cash reported on the condensed consolidated balance sheets that sum to the total cash, cash equivalents and restricted cash as of April 30, 2021 and January 29, 2021 (table in millions):
April 30,January 29,
20212021
Cash and cash equivalents$5,594 $4,692 
Restricted cash within other current assets58 56 
Restricted cash within other assets15 22 
Total cash, cash equivalents and restricted cash$5,667 $4,770 
Amounts included in restricted cash primarily relate to certain employee-related benefits, as well as amounts related to installment payments to certain employees as part of acquisitions, subject to the achievement of specified future employment conditions.
Short-Term Investments
Short-term investments totaled $120 million and $23 million as of April 30, 2021 and January 29, 2021, respectively, and consisted of marketable equity securities. Short-term investments as of April 30, 2021 consisted of marketable equity securities that were previously subject to a certain sale restriction and therefore were classified as other assets on the condensed consolidated balance sheet as of January 29, 2021. Refer to Note I for more information regarding the Company’s marketable equity securities.